Winfield Associates’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-35
Closed -$1K 882
2017
Q2
$1K Sell
35
-45
-56% -$785 ﹤0.01% 814
2017
Q1
$1K Buy
80
+45
+129% +$835 ﹤0.01% 700
2016
Q4
$1K Buy
+35
New +$628 ﹤0.01% 667

Other funds holding THC

Winfield Associates's THC Position: Q3 2017 in Review

Winfield Associates sold out of Tenet Healthcare (THC) in Q3 2017, closing a stake of 35 shares — an estimated $1K sold.

Winfield Associates first reported a position in THC in Q4 2016 and held it in 3 quarters. The position peaked at $1K in Q2 2017. 243 funds tracked by Wall St. Rank hold THC as of Q3 2017.

  • Winfield Associates reported no remaining Tenet Healthcare position as of Q3 2017 after selling out during the quarter.
  • Winfield Associates sold 35 Tenet Healthcare shares in Q3 2017, an estimated $1K.
  • Winfield Associates first reported a position in Tenet Healthcare in Q4 2016 and held it in 3 quarters.
  • Winfield Associates's Tenet Healthcare position peaked at $1K in Q2 2017.
  • 243 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2017.

Based on Winfield Associates's 13F filing for Q3 2017, filed 6 Nov 2017.